Stay updated on Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.

Latest updates to the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows 'Results Submitted' in place of 'No Results Posted', indicating that results submission is in progress.SummaryDifference0.1%

- Check8 days agoChange DetectedLocations section is added with Massachusetts listed as a site, replacing the previous Massachusetts Locations entry. The footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 replaces the previous Revision: v3.2.0 on the study page. The update appears to be administrative and does not alter trial details or eligibility.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page removed a government funding status notice regarding NIH operations; this is a non-critical site notice and does not alter the clinical trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedThe new screenshot shows minor updates, including a refreshed 'Last Update' timestamp and some formatting tweaks; core study details (title, purpose, arms, eligibility, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check86 days agoChange DetectedMajor addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.SummaryDifference4%

Stay in the know with updates to Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.